BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 26296642)

  • 21. Association of Genetically Predicted Fibroblast Growth Factor-23 with Heart Failure: A Mendelian Randomization Study.
    Akwo E; Pike MM; Ertuglu LA; Vartanian N; Farber-Eger E; Lipworth L; Perwad F; Siew E; Hung A; Bansal N; de Boer I; Kestenbaum B; Cox NJ; Ikizler TA; Wells Q; Robinson-Cohen C
    Clin J Am Soc Nephrol; 2022 Aug; 17(8):1183-1193. PubMed ID: 35902130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adult height and risk of 50 diseases: a combined epidemiological and genetic analysis.
    Lai FY; Nath M; Hamby SE; Thompson JR; Nelson CP; Samani NJ
    BMC Med; 2018 Oct; 16(1):187. PubMed ID: 30355295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mendelian randomization analyses identified bioavailable testosterone mediates the effect of sex hormone-binding globulin on prostate cancer.
    Wan B; Lu L; Lv C
    Andrology; 2023 Sep; 11(6):1023-1030. PubMed ID: 36524281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mendelian randomization study of height and risk of colorectal cancer.
    Thrift AP; Gong J; Peters U; Chang-Claude J; Rudolph A; Slattery ML; Chan AT; Esko T; Wood AR; Yang J; Vedantam S; Gustafsson S; Pers TH; ; Baron JA; Bezieau S; Küry S; Ogino S; Berndt SI; Casey G; Haile RW; Du M; Harrison TA; Thornquist M; Duggan DJ; Le Marchand L; Lemire M; Lindor NM; Seminara D; Song M; Thibodeau SN; Cotterchio M; Win AK; Jenkins MA; Hopper JL; Ulrich CM; Potter JD; Newcomb PA; Schoen RE; Hoffmeister M; Brenner H; White E; Hsu L; Campbell PT
    Int J Epidemiol; 2015 Apr; 44(2):662-72. PubMed ID: 25997436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers.
    Qian F; Rookus MA; Leslie G; Risch HA; Greene MH; Aalfs CM; Adank MA; Adlard J; Agnarsson BA; Ahmed M; Aittomäki K; Andrulis IL; Arnold N; Arun BK; Ausems MGEM; Azzollini J; Barrowdale D; Barwell J; Benitez J; Białkowska K; Bonadona V; Borde J; Borg A; Bradbury AR; Brunet J; Buys SS; Caldés T; Caligo MA; Campbell I; Carter J; Chiquette J; Chung WK; Claes KBM; Collée JM; Collonge-Rame MA; Couch FJ; Daly MB; Delnatte C; Diez O; Domchek SM; Dorfling CM; Eason J; Easton DF; Eeles R; Engel C; Evans DG; Faivre L; Feliubadaló L; Foretova L; Friedman E; Frost D; Ganz PA; Garber J; Garcia-Barberan V; Gehrig A; Glendon G; Godwin AK; Gómez Garcia EB; Hamann U; Hauke J; Hopper JL; Hulick PJ; Imyanitov EN; Isaacs C; Izatt L; Jakubowska A; Janavicius R; John EM; Karlan BY; Kets CM; Laitman Y; Lázaro C; Leroux D; Lester J; Lesueur F; Loud JT; Lubiński J; Łukomska A; McGuffog L; Mebirouk N; Meijers-Heijboer HEJ; Meindl A; Miller A; Montagna M; Mooij TM; Mouret-Fourme E; Nathanson KL; Nehoray B; Neuhausen SL; Nevanlinna H; Nielsen FC; Offit K; Olah E; Ong KR; Oosterwijk JC; Ottini L; Parsons MT; Peterlongo P; Pfeiler G; Pradhan N; Radice P; Ramus SJ; Rantala J; Rennert G; Robson M; Rodriguez GC; Salani R; Scheuner MT; Schmutzler RK; Shah PD; Side LE; Simard J; Singer CF; Steinemann D; Stoppa-Lyonnet D; Tan YY; Teixeira MR; Terry MB; Thomassen M; Tischkowitz M; Tognazzo S; Toland AE; Tung N; van Asperen CJ; van Engelen K; van Rensburg EJ; Venat-Bouvet L; Vierstraete J; Wagner G; Walker L; Weitzel JN; Yannoukakos D; ; ; ; ; Antoniou AC; Goldgar DE; Olopade OI; Chenevix-Trench G; Rebbeck TR; Huo D;
    Br J Cancer; 2019 Jul; 121(2):180-192. PubMed ID: 31213659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study.
    Au Yeung SL; Schooling CM
    BMJ Open Diabetes Res Care; 2019; 7(1):e000872. PubMed ID: 31908803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of genetic variation to separate the effects of early and later life adiposity on disease risk: mendelian randomisation study.
    Richardson TG; Sanderson E; Elsworth B; Tilling K; Davey Smith G
    BMJ; 2020 May; 369():m1203. PubMed ID: 32376654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rho GTPase gene expression and breast cancer risk: a Mendelian randomization analysis.
    Kazmi N; Robinson T; Zheng J; Kar S; Martin RM; Ridley AJ
    Sci Rep; 2022 Jan; 12(1):1463. PubMed ID: 35087170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mendelian randomisation analysis of circulating adipokines and C-reactive protein on breast cancer risk.
    Robinson T; Martin RM; Yarmolinsky J
    Int J Cancer; 2020 Sep; 147(6):1597-1603. PubMed ID: 32134113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer risk in patients with polycystic ovary syndrome: a Mendelian randomization analysis.
    Wen Y; Wu X; Peng H; Li C; Jiang Y; Su Z; Liang H; Liu J; He J; Liang W
    Breast Cancer Res Treat; 2021 Feb; 185(3):799-806. PubMed ID: 33128677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer risk factors and their effects on survival: a Mendelian randomisation study.
    Escala-Garcia M; Morra A; Canisius S; Chang-Claude J; Kar S; Zheng W; Bojesen SE; Easton D; Pharoah PDP; Schmidt MK
    BMC Med; 2020 Nov; 18(1):327. PubMed ID: 33198768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.
    Dixon-Suen SC; Nagle CM; Thrift AP; Pharoah PDP; Ewing A; Pearce CL; Zheng W; ; Chenevix-Trench G; Fasching PA; Beckmann MW; Lambrechts D; Vergote I; Lambrechts S; Van Nieuwenhuysen E; Rossing MA; Doherty JA; Wicklund KG; Chang-Claude J; Jung AY; Moysich KB; Odunsi K; Goodman MT; Wilkens LR; Thompson PJ; Shvetsov YB; Dörk T; Park-Simon TW; Hillemanns P; Bogdanova N; Butzow R; Nevanlinna H; Pelttari LM; Leminen A; Modugno F; Ness RB; Edwards RP; Kelley JL; Heitz F; du Bois A; Harter P; Schwaab I; Karlan BY; Lester J; Orsulic S; Rimel BJ; Kjær SK; Høgdall E; Jensen A; Goode EL; Fridley BL; Cunningham JM; Winham SJ; Giles GG; Bruinsma F; Milne RL; Southey MC; Hildebrandt MAT; Wu X; Lu KH; Liang D; Levine DA; Bisogna M; Schildkraut JM; Berchuck A; Cramer DW; Terry KL; Bandera EV; Olson SH; Salvesen HB; Thomsen LCV; Kopperud RK; Bjorge L; Kiemeney LA; Massuger LFAG; Pejovic T; Bruegl A; Cook LS; Le ND; Swenerton KD; Brooks-Wilson A; Kelemen LE; Lubiński J; Huzarski T; Gronwald J; Menkiszak J; Wentzensen N; Brinton L; Yang H; Lissowska J; Høgdall CK; Lundvall L; Song H; Tyrer JP; Campbell I; Eccles D; Paul J; Glasspool R; Siddiqui N; Whittemore AS; Sieh W; McGuire V; Rothstein JH; Narod SA; Phelan C; Risch HA; McLaughlin JR; Anton-Culver H; Ziogas A; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Wu AH; Pike MC; Tseng CC; Kupryjanczyk J; Dansonka-Mieszkowska A; Budzilowska A; Rzepecka IK; Webb PM;
    Br J Cancer; 2018 Apr; 118(8):1123-1129. PubMed ID: 29555990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Body size and composition and risk of site-specific cancers in the UK Biobank and large international consortia: A mendelian randomisation study.
    Vithayathil M; Carter P; Kar S; Mason AM; Burgess S; Larsson SC
    PLoS Med; 2021 Jul; 18(7):e1003706. PubMed ID: 34324486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying actionable druggable targets for breast cancer: Mendelian randomization and population-based analyses.
    Zhang N; Li Y; Sundquist J; Sundquist K; Ji J
    EBioMedicine; 2023 Dec; 98():104859. PubMed ID: 38251461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major depression disorder may causally associate with the increased breast cancer risk: Evidence from two-sample mendelian randomization analyses.
    Ren Q; Luo F; Ge S; Chen P
    Cancer Med; 2023 Jan; 12(2):1984-1996. PubMed ID: 35852181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone mineral density and risk of breast cancer: A cohort study and Mendelian randomization analysis.
    Zhang Y; Mao X; Yu X; Huang X; He W; Yang H
    Cancer; 2022 Jul; 128(14):2768-2776. PubMed ID: 35511874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the Causal Relationship of Maternal Height on Birth Size and Gestational Age at Birth: A Mendelian Randomization Analysis.
    Zhang G; Bacelis J; Lengyel C; Teramo K; Hallman M; Helgeland Ø; Johansson S; Myhre R; Sengpiel V; Njølstad PR; Jacobsson B; Muglia L
    PLoS Med; 2015 Aug; 12(8):e1001865. PubMed ID: 26284790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between weight at birth and breast cancer risk revisited using Mendelian randomisation.
    Kar SP; Andrulis IL; Brenner H; Burgess S; Chang-Claude J; Considine D; Dörk T; Evans DGR; Gago-Domínguez M; Giles GG; Hartman M; Huo D; Kaaks R; Li J; Lophatananon A; Margolin S; Milne RL; Muir KR; Olsson H; Punie K; Radice P; Simard J; Tamimi RM; Van Nieuwenhuysen E; Wendt C; Zheng W; Pharoah PDP
    Eur J Epidemiol; 2019 Jun; 34(6):591-600. PubMed ID: 30737679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smoking, alcohol consumption, and cancer: A mendelian randomisation study in UK Biobank and international genetic consortia participants.
    Larsson SC; Carter P; Kar S; Vithayathil M; Mason AM; Michaëlsson K; Burgess S
    PLoS Med; 2020 Jul; 17(7):e1003178. PubMed ID: 32701947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory cytokines and two subtypes of breast cancer: A two-sample mendelian randomization study.
    Zhou H; Cai Z; Yang Q; Yang X; Chen J; Huang T
    PLoS One; 2023; 18(11):e0293230. PubMed ID: 37910571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.